Skip to content

PRESSURE BIOSCIENCES, INC.: 10-Q filed 2020-11-16

What PRESSURE BIOSCIENCES, INC. reported in its quarterly report filed 2020-11-16 (fiscal Q3 2020): 36 published measures, 101 facts as tagged in accession 0001493152-20-021691.

This filing

Form
10-Q (quarterly report)
Filed
2020-11-16
Fiscal period
fiscal Q3 2020
Accession
0001493152-20-021691 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PRESSURE BIOSCIENCES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-09-302,957,481USD
At 2019-12-311,816,034USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-09-3017,493,861USD
At 2019-12-3113,871,441USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-09-30-14,536,380USD
At 2020-06-30-14,211,986USD
At 2020-03-31-13,659,933USD
At 2019-12-31-12,055,407USD
At 2019-09-30-9,624,529USD
At 2019-06-30-8,182,100USD
At 2019-03-31-6,772,741USD
At 2018-12-31-6,125,071USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-09-3094,752USD
At 2019-12-3129,625USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-3,278,748USD92
2020-01-01 to 2020-09-30-11,801,415USD274
2020-04-01 to 2020-06-30-4,568,782USD91
2020-01-01 to 2020-03-31-3,953,855USD91
2019-07-01 to 2019-09-30-3,156,829USD92
2019-01-01 to 2019-09-30-7,978,844USD273
2019-04-01 to 2019-06-30-2,766,842USD91
2019-01-01 to 2019-03-31-2,055,173USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-3,906,764USD274
2019-01-01 to 2019-09-30-5,019,345USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2020-01-01 to 2020-09-301,663USD274
2019-01-01 to 2019-09-3028,915USD273

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2020-07-01 to 2020-09-30533,862USD92
2020-01-01 to 2020-09-301,055,889USD274
2019-07-01 to 2019-09-30501,158USD92
2019-01-01 to 2019-09-301,530,061USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2020-01-01 to 2020-09-304,774,804USD274
2019-01-01 to 2019-09-305,080,506USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-802,913USD274
2019-01-01 to 2019-09-30-28,915USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-09-30-91,862,218USD
At 2019-12-31-78,942,277USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2019-07-01 to 2019-09-30217,168USD92
2019-01-01 to 2019-09-30217,168USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-09-3018,733USD
At 2019-12-3155,590USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2020-07-01 to 2020-09-3066,542USD92
2020-01-01 to 2020-09-30373,652USD274
2019-07-01 to 2019-09-30115,002USD92
2019-01-01 to 2019-09-30722,576USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-818,762USD92
2020-01-01 to 2020-09-30-3,544,494USD274
2019-07-01 to 2019-09-30-1,068,991USD92
2019-01-01 to 2019-09-30-3,866,227USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-09-301,902,405USD
At 2019-12-311,090,292USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2020-07-01 to 2020-09-302,204,593USD92
2020-01-01 to 2020-09-305,501,272USD274
2019-07-01 to 2019-09-302,124,477USD92
2019-01-01 to 2019-09-304,001,711USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-09-3016,940,865USD
At 2019-12-3113,853,376USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-09-30706,319USD
At 2019-12-31815,764USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2020-09-30330,459USD
At 2019-12-31229,402USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2020-07-01 to 2020-09-301,352,624USD92
2020-01-01 to 2020-09-304,600,383USD274
2019-07-01 to 2019-09-301,570,149USD92
2019-01-01 to 2019-09-305,396,288USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2020-09-30516,205USD
At 2019-12-31617,716USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2020-07-01 to 2020-09-30247,432USD92
2020-01-01 to 2020-09-30807,724USD274
2019-07-01 to 2019-09-30276,712USD92
2019-01-01 to 2019-09-30832,954USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-09-303,839,256shares
At 2019-12-312,549,620shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2020-09-3049,079,182USD
At 2019-12-3144,261,105USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2020-09-3020,958USD
At 2019-12-3176,586USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2020-09-30136,385USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2020-09-30512,019USD
At 2019-12-31576,923USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2020-09-30159,739USD
At 2019-12-31213,549USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-3,675,718USD92
2020-01-01 to 2020-09-30-12,919,941USD274
2019-07-01 to 2019-09-30-4,325,302USD92
2019-01-01 to 2019-09-30-11,873,147USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2020-07-01 to 2020-09-30684,807USD92
2020-01-01 to 2020-09-302,711,032USD274
2019-07-01 to 2019-09-30874,611USD92
2019-01-01 to 2019-09-303,155,800USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-2,459,986USD92
2020-01-01 to 2020-09-30-8,256,921USD274
2019-07-01 to 2019-09-30-2,305,006USD92
2019-01-01 to 2019-09-30-4,329,785USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2020-01-01 to 2020-09-30530,009USD274
2019-01-01 to 2019-09-302,571,231USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-30101,057USD274
2019-01-01 to 2019-09-30-63,388USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-101,511USD274
2019-01-01 to 2019-09-30-51,593USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-109,445USD274
2019-01-01 to 2019-09-30838,278USD273

Inspect the source

Entity
PRESSURE BIOSCIENCES, INC. / CIK 0000830656
Captured
2026-09-21T17:17:15.791Z
SEC response SHA-256
9f53d6670ff4d2eff56cabbc6920a9205a8540e6e5042ac9d3ad7d038501b96e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000830656.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))